EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Current State of Animal (Mouse) Modeling in Melanoma Research

Omer F Kuzu, Felix D Nguyen, Mohammad A Noory, Arati Sharma

Cancer Growth and Metastasis · 2015-01 · 8s1 · CGM.S21214

DOI: 10.4137/cgm.s21214 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Growth and Metastasis, online erschienen am 06.10.2015. Verfasst von Omer F Kuzu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, The Pennsylvania State University College of Medicine, Hershey, PA, USA. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the considerable progress in understanding the biology of human cancer and technological advancement in drug discovery, treatment failure remains an inevitable outcome for most cancer patients with advanced diseases, including melanoma. Despite FDA-approved BRAF-targeted therapies for advanced stage melanoma showed a great deal of promise, development of rapid resistance limits the success. Hence, the overall success rate of melanoma therapy still remains to be one of the worst compared to other malignancies. Advancement of next-generation sequencing technology allowed better identification of alterations that trigger melanoma development. As development of successful therapies strongly depends on clinically relevant preclinical models, together with the new findings, more advanced melanoma models have been generated. In this article, besides traditional mouse models of melanoma, we will discuss recent ones, such as patient-derived tumor xenografts, topically inducible BRAF mouse model and RCAS/TVA-based model, and their advantages as well as limitations. Although mouse models of melanoma are often criticized as poor predictors of whether an experimental drug would be an effective treatment, development of new and more relevant models could circumvent this problem in the near future.

Schlagwörter

Stichwörter der Autor:innen

genetically engineered mouse models (GEMMs)melanomapatient-derived tumor xenografts (PDTXs)syngeneic modelsxenografts

Autor:innen und Institutionen

  • Department of Pharmacology, The Pennsylvania State University College of Medicine, Hershey, PA, USA.
  • The University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Förderung

  • NCI NIH HHS

Zitieren

APA

Kuzu, O. F., Nguyen, F. D., Noory, M. A., & Sharma, A. (2015). Current State of Animal (Mouse) Modeling in Melanoma Research. Cancer Growth and Metastasis, 8s1, CGM.S21214. https://doi.org/10.4137/cgm.s21214

Vancouver

Kuzu OF, Nguyen FD, Noory MA, Sharma A. Current State of Animal (Mouse) Modeling in Melanoma Research. Cancer Growth and Metastasis. 2015;8s1:CGM.S21214. doi:10.4137/cgm.s21214

BibTeX
@article{Kuzu2015,
  author = {Kuzu, Omer F and Nguyen, Felix D and Noory, Mohammad A and Sharma, Arati},
  title = {Current State of Animal (Mouse) Modeling in Melanoma Research},
  journal = {Cancer Growth and Metastasis},
  year = {2015},
  volume = {8s1},
  pages = {CGM.S21214},
  doi = {10.4137/cgm.s21214}
}
Kostenlos starten →